Elaine A. Gay

Elaine A. Gay

Auto-generated profile, based on publicly available information

Elaine A. Gay

Center for Drug Discovery, RTI International, Research Triangle Park, NC 27709, USA

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 March 2017 in Journal of Biomedical Science
Verified
Journal Article
Open access
PDF file
ADAnn M. Decker
Ann M. Decker
EGElaine A. Gay
Elaine A. Gay
KMKelly M. Mathews
Kelly M. Mathews
TRTaylor C. Rosa
Taylor C. Rosa
TLTiffany L. Langston
Tiffany L. Langston
CJChunyang Jin
Chunyang Jin
GPR88 is an orphan G protein-coupled receptor highly expressed in the striatum and is implicated in basal ganglia-associated disorders. However, the receptor functions of GPR88 are still largely unknown due to the lack of potent and selective ligands appropriate for central nervous system investigation. Development of a high-throughput screening assay for GPR88 should facilitate the discovery of novel ligands to probe GPR88 functions. In this paper, we describe the development of a CHO-Gαqi5-GPR88 cell-based calcium mobilization assay. The assay takes advantage of functional coupling of GPR88 with the promiscuous Gαqi5 protein and consequent mobilization of intracellular calcium, which can be measured in a 384-well format with a Fluorescent Imaging Plate Reader. The CHO-Gαqi5-GPR88 cell-based calcium mobilization assay was validated by the structure-activity relationship study of known GPR88 agonist (1R,2R)-2-PCCA analogues. The assay was automated and miniaturized to a 384-well format, and was deemed robust and reproducible with a Z’-factor of 0.72 and tolerated dimethyl sulfoxide to a final concentration of 2%. Screening a pilot neurotransmitter library consisting of 228 compounds yielded 10 hits, but none of the hits were confirmed as GPR88 agonists in follow-up assays. We have developed a high-throughput calcium mobilization assay for the orphan receptor GPR88. This calcium mobilization assay can be used to identify several different types of GPR88 ligands including agonists, competitive and noncompetitive antagonists, inverse agonists, and allosteric modulators. These ligands will serve as valuable tools to probe signaling mechanisms and in vivo functions of GPR88, and could expedite development of novel therapies for diseases potentially mediated by GPR88.

2 August 2023 in Bioorganic & Medicinal Chemistry Letters
Verified
Journal Article
Closed access
EGElaine A. Gay
Elaine A. Gay
DHDanni Harris
Danni Harris
JWJoseph W. Wilson
Joseph W. Wilson
BBbruce blough
bruce blough

6 October 2021 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
AZAllison Zarkin
Allison Zarkin
RJRajwana Jahan
Rajwana Jahan
RURajendra Uprety
Rajendra Uprety
YZYanan Zhang
Yanan Zhang
CMChuck McElhinny
Chuck McElhinny
SRscott runyon
scott runyon
Activation of the neuropeptide S receptor (NPSR) system has been shown to produce anxiolytic-like actions, arousal, and enhance memory consolidation, whereas blockade of the NPSR has been shown to reduce relapse to substances of abuse and duration of anesthetics. We report here the discovery of a novel core scaffold (+) N-benzyl-3-(2-methylpropyl)-1-oxo-3-phenyl-1H,3H,4H,5H,6H,7H-furo[3,4-c]pyridine-5-carboxamide with potent NPSR antagonist activity in vitro. Pharmacokinetic parameters demonstrate that 14b reaches pharmacologically relevant levels in plasma and the brain following intraperitoneal (i.p.) administration, but is cleared rapidly from plasma. Compound 14b was able to block NPS (0.3 nmol)-stimulated locomotor activity in C57/Bl6 mice at 3 mg/kg (i.p.), indicating potent in vivo activity for the structural class. This suggests that 14b can serve as a useful tool for continued mapping of the pharmacological functions of the NPS receptor system.